Adquisición de la especialidad farmacéutica, VISIPAQUE® SOLUCIÓN INYECTABLE, 320 I/652 MG 100 ML C/10, 320 MG 500 ML FRASCO C/6 y 320 MG 50 ML FRASCO C/10 (IODIXANOL), con destino al Servicio de Farmacia de Hospital Universitario Ramón y Cajal
TED · 656706-2026Award noticeawardedNo deadline given
Value
Estimated€1,496,880 · 1,496,880 EUR
Awarded€1,496,880 · 1,496,880 EUR
WinnerGE Healthcare Bio-Sciences, S.A.U
Who already wins at this buyer
Firms with recorded awards from HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| VERTEX PHARMACEUTICALS SPAIN, S.L. | 3 | €6,205,465 | 2026-09-18 |
| JANSSEN CILAG S.A | 3 | €2,351,724 | 2026-07-30 |
| ROCHE FARMA SAU | 2 | €3,678,270 | 2026-07-07 |
| BRISTOL MYERS SQUIBB S.A.U. | 1 | €2,823,840 | 2026-06-24 |
| ALCON HEALTHCARE,S.A.U. | 1 | €1,823,377 | 2026-09-23 |
Full buyer profile: what HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL buys and who wins it →
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
Adquisición de la especialidad farmacéutica, VISIPAQUE® SOLUCIÓN INYECTABLE, 320 I/652 MG 100 ML C/10, 320 MG 500 ML FRASCO C/6 y 320 MG 50 ML FRASCO C/10 (IODIXANOL), con destino al Servicio de Farmacia de Hospital Universitario Ramón y Cajal
Similar tenders
Closest by meaning — across languages, via embeddings.